Status:
COMPLETED
Development of a Reference Interval Database With the NeuroCatch™ Platform
Lead Sponsor:
NeuroCatch Inc.
Conditions:
Brain Health
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
The NeuroCatch Platform™, an investigational medical device system developed by NeuroCatch Inc., consists of software and hardware that captures brain health information. The platform intends to provi...
Eligibility Criteria
Inclusion
- Any sex, at least 8 years of age or older
- Able to understand the informed consent/assent form, study procedures and willing to participate in study
- Able to remain seated and focused for 6 minutes
- Normal hearing capabilities
Exclusion
- Clinically documented hearing issues (e.g. tinnitus, in-ear hearing problems or punctured ear drum)
- Implanted pacemaker or implanted electrical stimulators
- Metal or plastic implants in skull
- Exposed to an investigational drug or device 30 days prior to start in this study, or concurrent or planned use of investigational drug or device while enrolled in this study
- Not proficient in English language
- Previous exposure to the NeuroCatch™ Platform audio sequences in the last 6 months
- If female and of child-bearing potential: pregnant, suspected or planning to become pregnant or breast-feeding
- History of seizures
- Allergy to rubbing alcohol or EEG gel
- Unhealthy scalp (apparent open wounds and/or bruised or weakened skin)
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03835962
Start Date
March 1 2019
End Date
January 31 2020
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthTech Connex Centre for Neurology Studies
Surrey, British Columbia, Canada, V3V 0C6